Delivery Order SPE2DB20D2002-SPE2DB22FL36E
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,615.05 for the supply of 4556120380 - BROMSITE 0.075% EYE DROPS 5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 2, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $6,581.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Bromsite 0.075% eye drops, a specialty medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,227.06 for the supply of Bromfenac Sodium 0.09% eye drops. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,024.26 for Bromfenac Sodium 0.09% eye drops. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of July 29, 2021. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award is for the procurement of BROMSITE 0.075% eye drops, with a ceiling value of $4,466.70. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award with a ceiling value of $4,421.74 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of BROMSITE 0.075% eye drops in 5 milliliter bottles, to be delivered by March 16, 2023. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $5,407.10 delivery order for fluorometholone 0.1% eye drops. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a completion date of September 13, 2023. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of COSOPT PF eye drops. The $1,349.20 firm fixed-price contract has a completion date of September 13, 2023. This contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,177.54 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, a specialty pharmaceutical product. The award is part of a larger, previously awarded Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the primary vehicle for...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL36EDelivery Order
This federal contract award, valued at $3,824.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4557054812 - BROMSITE 0.075% EYE DROPS 5ML, a pharmaceutical product. The award has an ultimate completion date of May 2, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. The contract award was made through full and open competition, with no set-aside designation. This indicates that Amerisourcebergen Drug Corp, as a subsidiary of the parent company Cencora, Inc., has established itself as a key supplier of pharmaceutical and medical products to various federal agencies, particularly the DLA and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/29/22 |